Absorption |
Blood-Brain Barrier | BBB+ | 0.9766 |
Human Intestinal Absorption | HIA+ | 0.9907 |
Caco-2 Permeability | Caco2+ | 0.7407 |
P-glycoprotein Substrate | Non-substrate | 0.8420 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9751 |
Non-inhibitor | 0.9839 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9158 |
Distribution |
Subcellular localization | Lysosome | 0.6352 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7952 |
CYP450 2D6 Substrate | Non-substrate | 0.8462 |
CYP450 3A4 Substrate | Non-substrate | 0.7982 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9103 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9626 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9758 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9783 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9862 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9175 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9482 |
Non-inhibitor | 0.9738 |
AMES Toxicity | Non AMES toxic | 0.9732 |
Carcinogens | Carcinogens | 0.6995 |
Fish Toxicity | Low FHMT | 0.6105 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.7136 |
Honey Bee Toxicity | High HBT | 0.8235 |
Biodegradation | Ready biodegradable | 0.6385 |
Acute Oral Toxicity | III | 0.7149 |
Carcinogenicity (Three-class) | Non-required | 0.4942 |